Harmony Biosciences
HRMYNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$1.909 B
$32.51 -5.54%
Close of 6 Nov 2026
As of 6 Nov 2026, Harmony Biosciences (HRMY) has a market capitalization of $1.91B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$868.5M
#1591 by revenue
Earnings
$158.7M
#1098 by earnings
Shares outstanding
58,723,199
Latest filing cover page
P/E ratio
12.0
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #96ZymeworksZYME$2.03B
- #97First Tracks BiotherapeuticsTRAX$1.92B
- #98Harmony BiosciencesHRMY$1.91B
- #99Sarepta TherapeuticsSRPT$1.85B
- #100Trevi TherapeuticsTRVI$1.84B
What if Harmony Biosciences were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Harmony Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.